Recent studies have also demonstrated the application of next-generation sequencing (NGS) technologies for the detection of KMT2A-r, which also facilitates the identification of numerous genomic alterations for risk classification of acute leukemia (Shiba et al., 2019; Brown et al., 2020). The gene discussed is KMT2A; the disease is acute leukemia.